Your browser doesn't support javascript.
loading
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.
Hodgkinson, Cassandra L; Morrow, Christopher J; Li, Yaoyong; Metcalf, Robert L; Rothwell, Dominic G; Trapani, Francesca; Polanski, Radoslaw; Burt, Deborah J; Simpson, Kathryn L; Morris, Karen; Pepper, Stuart D; Nonaka, Daisuke; Greystoke, Alastair; Kelly, Paul; Bola, Becky; Krebs, Matthew G; Antonello, Jenny; Ayub, Mahmood; Faulkner, Suzanne; Priest, Lynsey; Carter, Louise; Tate, Catriona; Miller, Crispin J; Blackhall, Fiona; Brady, Ged; Dive, Caroline.
Afiliação
  • Hodgkinson CL; 1] Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2].
  • Morrow CJ; 1] Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2].
  • Li Y; Computational Biology Support Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Metcalf RL; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Rothwell DG; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Trapani F; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Polanski R; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Burt DJ; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Simpson KL; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Morris K; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Pepper SD; Molecular Biology Core Facility, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Nonaka D; The Christie NHS Foundation Trust, Manchester, UK.
  • Greystoke A; 1] Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2] The Christie NHS Foundation Trust, Manchester, UK. [3] Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Kelly P; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Bola B; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Krebs MG; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Antonello J; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Ayub M; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Faulkner S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Priest L; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Carter L; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Tate C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Miller CJ; 1] Computational Biology Support Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2] RNA Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • Blackhall F; 1] The Christie NHS Foundation Trust, Manchester, UK. [2] Institute of Cancer Sciences, University of Manchester, Manchester, UK. [3].
  • Brady G; 1] Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2].
  • Dive C; 1] Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. [2].
Nat Med ; 20(8): 897-903, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24880617
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2014 Tipo de documento: Article